These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15345480)

  • 21. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation.
    Flemming MA; Oral H; Rothman ED; Briesmiester K; Petrusha JA; Starling MR
    Am Heart J; 2000 Sep; 140(3):476-82. PubMed ID: 10966551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular systolic function assessment in secondary mitral regurgitation: left ventricular ejection fraction vs. speckle tracking global longitudinal strain.
    Kamperidis V; Marsan NA; Delgado V; Bax JJ
    Eur Heart J; 2016 Mar; 37(10):811-6. PubMed ID: 26685140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic mapping of left ventricular regional contractile injury in ischemic mitral regurgitation.
    Lancaster TS; Kar J; Cupps BP; Henn MC; Kulshrestha K; Koerner DJ; Pasque MK
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):149-158.e1. PubMed ID: 28109612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doppler-derived preoperative mitral regurgitation volume predicts postoperative left ventricular dysfunction after mitral valve repair.
    Yamano T; Gillinov AM; Wada N; Matsumura Y; Toyono M; Thomas JD; Shiota T
    Am Heart J; 2009 May; 157(5):875-82. PubMed ID: 19376314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In patients with post-infarction left ventricular dysfunction, how does impaired basal rotation affect chronic ischemic mitral regurgitation?
    Zito C; Cusmà-Piccione M; Oreto L; Tripepi S; Mohammed M; Di Bella G; Falanga G; Oreto G; Lentini S; Carerj S
    J Am Soc Echocardiogr; 2013 Oct; 26(10):1118-1129. PubMed ID: 23727114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non-hypertensive diabetic rats (PPAR γ).
    Abou Daya K; Abu Daya H; Nasser Eddine M; Nahhas G; Nuwayri-Salti N
    J Diabetes; 2015 Jan; 7(1):85-94. PubMed ID: 24548695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring.
    Liu J; Sakurai R; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(8):L788-96. PubMed ID: 25659902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of ischemic mitral regurgitation. An experimental evaluation.
    Kaul S; Spotnitz WD; Glasheen WP; Touchstone DA
    Circulation; 1991 Nov; 84(5):2167-80. PubMed ID: 1934385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome.
    Pu M; Gao Z; Zhang X; Liao D; Pu DK; Brennan T; Davidson WR
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1727-32. PubMed ID: 19329766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction.
    Nagatsu M; Spinale FG; Koide M; Tagawa H; DeFreitas G; Cooper G; Carabello BA
    Circulation; 2000 Feb; 101(6):653-9. PubMed ID: 10673258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of left ventricular ejection fraction as a measure of pump performance in patients with chronic mitral regurgitation.
    Timmis SB; Kirsh MM; Montgomery DG; Starling MR
    Catheter Cardiovasc Interv; 2000 Mar; 49(3):290-6. PubMed ID: 10700061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function.
    Zile MR; Tomita M; Nakano K; Mirsky I; Usher B; Lindroth J; Carabello BA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1471-80. PubMed ID: 1951734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of mitral regurgitation in the acute phase of inferior wall myocardial infarction: reduced closing force as a consequence of left ventricular systolic dysfunction in the presence of tethering as a determinant of mitral regurgitation.
    Hong SJ; Kim SA; Hur J; Rhee SJ; Shim CY; Kim JS; Ko YG; Choi EY; Choi D; Jang Y; Chung N; Ha JW
    Circ J; 2011; 75(3):619-25. PubMed ID: 21233576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of left ventricular contractile function using noninvasively determined single-beat end-systolic elastance in mitral regurgitation: experimental validation and clinical application.
    Kim YJ; Jones M; Greenberg NL; Popovic ZB; Sitges M; Bauer F; Thomas JD; Shiota T
    J Am Soc Echocardiogr; 2007 Sep; 20(9):1086-92. PubMed ID: 17566701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular shape: a factor in the etiology of functional mitral regurgitation in heart failure.
    Sabbah HN; Kono T; Rosman H; Jafri S; Stein PD; Goldstein S
    Am Heart J; 1992 Apr; 123(4 Pt 1):961-6. PubMed ID: 1532283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in transmural myocardial strain: an early marker of left ventricular dysfunction in mitral regurgitation?
    Carlhäll CJ; Nguyen TC; Itoh A; Ennis DB; Bothe W; Liang D; Ingels NB; Miller DC
    Circulation; 2008 Sep; 118(14 Suppl):S256-62. PubMed ID: 18824764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.